Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report

EML4-ALK rearranged malignant pleural mesothelioma (MPM) is rare and its responses to anaplastic lymphoma kinase (ALK) inhibitors, including alectinib and lorlatinib, remain unexplored. In this case report, we describe a patient with EML4-ALK-rearranged stage IIIB MPM who was administered with alect...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Respir Dis
Egile Nagusiak: Hu, Jia, Zhang, Baoshi, Yao, Fangfang, Fu, Yan, Chen, Dianjun, Li, Donghui, Du, Nan, Lizaso, Analyn, Song, Jinlei, Zhang, Lu, Li, Xiaosong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7328355/
https://ncbi.nlm.nih.gov/pubmed/32600123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466620935770
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak